Table 2.
Antibiotic | Resistant/sensitive or MIC level (mg/L) | No. isolates | OD550 (mean ± SD) | P-value |
---|---|---|---|---|
Cefotaxime | Resistance | 83 | 1.16 ± 0.45 | 0.124 |
Sensitive | 161 | 1.26 ± 0.54 | ||
Ceftazidime | Resistance | 61 | 1.17 ± 0.46 | 0.243 |
Sensitive | 181 | 1.26 ± 0.54 | ||
Cefepime | Resistance | 71 | 1.16 ± 0.44 | 0.155 |
Sensitive | 171 | 1.25 ± 0.53 | ||
Cefoperazone-sulbactam | Resistance | 51 | 1.23 ± 0.50 | 0.914 |
Sensitive | 186 | 1.24 ± 0.52 | ||
Piperacillin-tazobactam | Resistance | 59 | 1.21 ± 0.49 | 0.513 |
Sensitive | 175 | 1.27 ± 0.53 | ||
Chloramphenicol | Resistance | 64 | 1.16 ± 0.39 | 0.152 |
Sensitive | 177 | 1.26 ± 0.55 | ||
Gentamicin | Resistance | 65 | 1.18 ± 0.39 | 0.258 |
Sensitive | 184 | 1.25 ± 0.26 | ||
Ciprofloxacin | Resistance | 65 | 1.17 ± 0.41 | 0.146 |
Sensitive | 175 | 1.26 ± 0.56 | ||
Levofloxacin | Resistance | 60 | 1.16 ± 0.42 | 0.173 |
Sensitive | 183 | 1.25 ± 0.55 | ||
Tetracycline | Resistance | 93 | 1.21 ± 0.46 | 0.716 |
Sensitive | 151 | 1.24 ± 0.55 | ||
ESBL production | Yes | 70 | 1.17 ± 0.43 | 0.222 |
No | 180 | 1.25 ± 0.55 | ||
Imipenem | MIC < 1 | 190 | 1.26 ± 0.56 | 0.101 |
1 ≤ MIC < 4 | 21 | 1.23 ± 0.37 | ||
MIC ≥ 4 | 39 | 1.07 ± 0.31 | ||
Meropenem | MIC < 1 | 177 | 1.27 ± 0.57 | 0.110 |
1 ≤ MIC < 4 | 19 | 1.17 ± 0.42 | ||
MIC ≥ 4 | 54 | 1.11 ± 0.29 | ||
Tigecycline | MIC < 1 | 72 | 1.20 ± 0.38 | 0.721 |
1 ≤ MIC < 4 | 145 | 1.25 ± 0.27 | ||
MIC ≥ 4 | 33 | 1.19 ± 0.56 | ||
Eravacycline | MIC < 1 | 164 | 1.27 ± 0.56 | 0.123 |
1 ≤ MIC < 4 | 74 | 1.18 ± 0.45 | ||
MIC ≥ 4 | 12 | 0.99 ± 0.20 |